FADD and T-cell non-Hodgkin lymphoma: Additional observations supporting the pro-survival role of phosphorylated FADD in cancer is the report that inhibition of FADD phosphorylation increases cisplatin-induced cell death in A549 lung cancer cells 33 and the report of increased FADD phosphorylation in T cell lymphomas 34.